Carson Wealth (CWM LLC)
VRDN icon

Carson Wealth (CWM LLC)’s Viridian Therapeutics VRDN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5K Buy
538
+16
+3% +$475 ﹤0.01% 4755
2025
Q4 		$16K Buy
522
+21
+4% +$576 ﹤0.01% 4312
2025
Q3 		$11K Buy
501
+74
+17% +$1.33K ﹤0.01% 4449
2025
Q2 		$6K Buy
427
+193
+82% +$2.62K ﹤0.01% 4571
2025
Q1 		$3K Buy
234
+106
+83% +$1.81K ﹤0.01% 4699
2024
Q4 		$2K Buy
128
+11
+9% +$239 ﹤0.01% 4624
2024
Q3 		$3K Buy
117
+25
+27% +$409 ﹤0.01% 4328
2024
Q2 		$1K Buy
+92
New +$1.27K ﹤0.01% 4514
2023
Q4 		– Sell
-14
Closed – – 4546
2023
Q3 		$0 Buy
+14
New +$267 ﹤0.01% 4558

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Carson Wealth (CWM LLC)'s VRDN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Viridian Therapeutics (VRDN) stake by 3.1% in Q1 2026, buying an estimated $475 and bringing the position to 538 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4755.

Carson Wealth (CWM LLC) first reported a position in VRDN in Q3 2023 and has held it in 9 quarters since. The position peaked at $16K in Q4 2025. 225 funds tracked by Wall St. Rank hold VRDN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 538 shares of Viridian Therapeutics worth $10.5K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 16 Viridian Therapeutics shares in Q1 2026, an estimated $475.
  • Viridian Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4755 holding.
  • Carson Wealth (CWM LLC) first reported a position in Viridian Therapeutics in Q3 2023 and has held it in 9 quarters since.
  • Carson Wealth (CWM LLC)'s Viridian Therapeutics position peaked at $16K in Q4 2025.
  • 225 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.